1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 13
1.2 List of Figures 23
2 Introduction 24
2.1 Women's Health Overview 24
3 Products under Development 25
3.1 Women's Health - Pipeline Products by Stage of Development 25
3.2 Women's Health - Pipeline Products by Territory 26
3.3 Women's Health - Pipeline Products by Regulatory Path 27
3.4 Women's Health - Pipeline Products by Estimated Approval Date 28
3.5 Women's Health - Ongoing Clinical Trials 29
4 Women's Health - Pipeline Products under Development by Companies 30
4.1 Women's Health Companies - Pipeline Products by Stage of Development 30
4.2 Women's Health - Pipeline Products by Stage of Development 34
5 Women's Health Companies and Product Overview 38
5.1 Accord Biomaterials, Inc. Company Overview 38
5.2 Acelity L.P. Inc. Company Overview 39
5.3 Advanced Prenatal Therapeutics, Inc. Company Overview 40
5.4 AEGEA Medical, Inc. Company Overview 41
5.5 Aethlon Medical Inc Company Overview 44
5.6 Allergan Plc Company Overview 46
5.7 AltaScience Limited Company Overview 50
5.8 Amniotix Technologies Ltd Company Overview 51
5.9 Aneeve Nanotechnologies LLC Company Overview 52
5.10 Atossa Genetics Inc Company Overview 53
5.11 Babyation LLC Company Overview 54
5.12 Bayer AG Company Overview 55
5.13 Bayer HealthCare AG Company Overview 58
5.14 Baylor College of Medicine Company Overview 59
5.15 Baystate Medical Center Company Overview 60
5.16 Becton Dickinson and Co Company Overview 61
5.17 Bioceptive Inc Company Overview 63
5.18 BioResonator Good Eye AB Company Overview 64
5.19 Biorings LLC Company Overview 65
5.20 Biostruxs LLC Company Overview 66
5.21 Birmont Medical Ltd. Company Overview 67
5.22 Boston Scientific Corp Company Overview 68
5.23 Cambridge Design Partner Ltd. Company Overview 70
5.24 Cath Med Ltd. Company Overview 71
5.25 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 72
5.26 CervoCheck, LLC Company Overview 73
5.27 Conrad Company Overview 74
5.28 Contramed LLC Company Overview 75
5.29 Dartmouth College Company Overview 78
5.30 Discreet Secrete Solutions Company Overview 79
5.31 Drexel University Company Overview 80
5.32 DS Labs, Inc Company Overview 81
5.33 Enox Biopharma Inc Company Overview 82
5.34 Ethicon Inc Company Overview 83
5.35 EVE Medical Systems Ltd Company Overview 84
5.36 Evofem Inc Company Overview 85
5.37 Femasys Inc. Company Overview 87
5.38 FemSuite LLC. Company Overview 90
5.39 Ferring Pharmaceuticals A/S Company Overview 92
5.40 Fibro Control Inc. Company Overview 93
5.41 Galmedics Biotech Ltd Company Overview 94
5.42 Global Health Partnerships Company Overview 95
5.43 Gynesonics Inc Company Overview 96
5.44 Healingstone Co Ltd Company Overview 98
5.45 Healthcare Enterprise Group PLC (Inactive) Company Overview 99
5.46 Igantia Therapeutics Company Overview 100
5.47 Impres Medical, Inc. Company Overview 101
5.48 In Veritas Medical Diagnostics Inc. (Inactive) Company Overview 102
5.49 Innometrix Company Overview 103
5.50 Inpress Technologies, Inc. Company Overview 104
5.51 iPulse Medical Ltd Company Overview 105
5.52 Jibon Health Technologies, Inc. Company Overview 106
5.53 Kerecis ehf Company Overview 109
5.54 KynderMed Inc Company Overview 110
5.55 Laboratoire HRA Pharma Company Overview 111
5.56 Madorra Company Overview 113
5.57 Materna Medical Inc. Company Overview 114
5.58 Mayo Clinic in Rochester Company Overview 117
5.59 McNEIL-PPC Inc Company Overview 118
5.60 Medela AG Company Overview 121
5.61 MEDITE Cancer Diagnostics Inc Company Overview 123
5.62 Medprin Regenerative Medical Technologies Co Ltd Company Overview 125
5.63 Mentor Worldwide LLC Company Overview 126
5.64 Merck & Co Inc Company Overview 130
5.65 Merck KGaA Company Overview 132
5.66 Merck Serono SA Company Overview 135
5.67 Mithra Pharmaceuticals SA Company Overview 137
5.68 Molecular Biometrics LLC Company Overview 138
5.69 Momtec Life Ltd. Company Overview 139
5.70 Nipro Corp Company Overview 140
5.71 Northwestern University Company Overview 142
5.72 Novomedics L L C Company Overview 145
5.73 Nuveta, Inc. Company Overview 146
5.74 Nvision Medical Corporation Company Overview 147
5.75 OCON Medical Ltd Company Overview 150
5.76 OmniBiome Therapeutics Inc Company Overview 157
5.77 OncoGenesis Company Overview 158
5.78 Ondine Biomedical Inc Company Overview 159
5.79 Onko Solutions, LLC Company Overview 161
5.80 OptiVia Medical, LLC Company Overview 162
5.81 ORATEL DIAGNOSTICS LLC Company Overview 163
5.82 Os Technology LLC Company Overview 164
5.83 OVATECH, Inc. Company Overview 165
5.84 Positive Care Ltd Company Overview 166
5.85 Progyny Inc Company Overview 167
5.86 Rambam Health Care Campus Company Overview 168
5.87 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 169
5.88 RevMedx, Inc. Company Overview 171
5.89 Shift Labs, Inc. Company Overview 172
5.90 Sientra Inc Company Overview 173
5.91 Soulor Surgical Inc (Inactive) Company Overview 175
5.92 Stanford University Company Overview 176
5.93 Strata Various Product Design Company Overview 177
5.94 Tecuro AG Company Overview 178
5.95 TeVido BioDevices, LLC Company Overview 179
5.96 The Cooper Companies Inc Company Overview 180
5.97 The Feinstein Institute for Medical Research Company Overview 182
5.98 The Pennsylvania State University Company Overview 184
5.99 Tiny Kicks LLC Company Overview 185
5.100 TruScreen Ltd Company Overview 186
5.101 Universitat Politecnica de Catalunya Company Overview 188
5.102 University of Auckland Company Overview 190
5.103 University of California San Francisco Company Overview 191
5.104 University of Florida Company Overview 193
5.105 University of Liverpool Company Overview 197
5.106 University of Minnesota Company Overview 199
5.107 University of South Florida Company Overview 200
5.108 Viveve, Inc. Company Overview 204
5.109 VivoSensMedical GmbH Company Overview 206
5.110 ZR-Operculum, Inc. Company Overview 208
6 Women's Health- Recent Developments 209
6.1 Dec 08, 2016: The Cooper Companies Announces Fourth Quarter and Full Year 2016 Results 209
6.2 Dec 07, 2016: Success For Myring European Clinical Trial 210
6.3 Dec 07, 2016: Abbott Seeks To Terminate Alere Acquisition 210
6.4 Dec 01, 2016: VIVEVE I Clinical Study Results Accepted for Publication in Journal of Sexual Medicine 210
6.5 Dec 01, 2016: Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million 211
6.6 Dec 01, 2016: Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million 212
6.7 Nov 29, 2016: Medela Introduces First Smart Breast Pump Designed with Moms in Mind 212
6.8 Nov 29, 2016: Lutronic Raises USD43.7 Million in Rights Offering of Preferred Shares 213
6.9 Nov 25, 2016: Active pharmaceutical ingredients: Japan joins international collaboration on GMP inspections 213
6.10 Nov 22, 2016: Materna Medical Raises USD4.6 Million in Venture Financing 213
6.11 Nov 18, 2016: Reproductive Medicine Associates of Texas and INVO Bioscience Announce Positive Patient Results Using the INVO Procedure 213
6.12 Nov 16, 2016: Bayer Raises USD4.3 Billion in Private Placement of Convertible Notes due 2019 214
6.13 Nov 15, 2016: Braster to Raise USD2.6 Million in Public Offering of Series A Bonds 214
6.14 Nov 15, 2016: Boston Scientific Acquires Resectr Tissue Resection Device from Distal Access 214
6.15 Nov 15, 2016: Dilon Diagnostics Enters into Distribution Agreement with GE Healthcare in North America 215
6.16 Nov 15, 2016: Merck Raises Profit Forecast for 2016 Following Good Third Quarter 215
6.17 Nov 15, 2016: NanoVibronix Provides Third Quarter 2016 Business Update 217
6.18 Nov 15, 2016: Juniper Pharmaceuticals Reports Third Quarter 2016 Financial Results 218
6.19 Nov 15, 2016: FDA approves Essure labeling with important safety information for patients and physicians 219
6.20 Nov 15, 2016: The Female Health Company names new president of global public health sector division 220
6.21 Nov 14, 2016: Hologic Launches Next-Generation NovaSure ADVANCED Global Endometrial Ablation System to Enhance the Treatment of Abnormal Uterine Bleeding 220
6.22 Nov 14, 2016: Medicines360 and Allergan Announce Study Publication Evaluating Pelvic Infection Risk Following Same-Day Sexually Transmitted Infection Testing and LILETTA (levonorgestrel-releasing intrauterine system) 52 mg Placement 221
6.23 Nov 14, 2016: Adriane M. Brown to Join Allergan Board of Directors 222
6.24 Nov 14, 2016: Atossa Genetics Announces Third Quarter 2016 Financial Results and Provides Company Update 222
6.25 Nov 10, 2016: Data from Sonata Technology Platform Featured in Presentations at AAGL Global Congress in Orlando 223
6.26 Nov 10, 2016: Aethlon Medical Announces Fiscal 2017 Second Quarter Results 224
6.27 Nov 09, 2016: Syneron Medical Reports Third Quarter 2016 Revenue of $71.5 Million 226
6.28 Nov 08, 2016: Sientra Reports Third Quarter 2016 Financial Results 227
6.29 Nov 06, 2016: CooperSurgical Acquires Wallace Product Line from Smiths Medical International for USD175.2 Million 228
6.30 Nov 04, 2016: Seegene Enters into Agreement with Hologic 228
6.31 Nov 04, 2016: Alere Reports Third Quarter 2016 Financial Results 228
6.32 Nov 04, 2016: The third quarter sees another rise in sales and earnings at the HARTMANN GROUP 228
6.33 Nov 03, 2016: BioMed X Enters into Agreement with Merck 229
6.34 Nov 03, 2016: BD Announces Results For 2016 Fourth Fiscal Quarter And Full Year; Provides Fiscal 2017 Guidance 230
6.35 Nov 03, 2016: Vitrolife: Interim Report January-September 2016: Good Growth in All Market Regions 231
6.36 Nov 02, 2016: Allergan Reports Third Quarter 2016 Continuing Operations Performance with GAAP Net Revenues of $3.6 Billion; Announces Accelerated Share Repurchase, Initiation of Cash Dividend 232
6.37 Nov 02, 2016: Hologic Announces Financial Results for Fourth Quarter of Fiscal 2016 236
6.38 Nov 02, 2016: Coloplast delivers full-year results in line with guidance 237
6.39 Oct 31, 2016: Halt Medical Enters into Licensing Agreement with InnerOptic Technology 238
6.40 Oct 27, 2016: McKesson Reports Fiscal 2017 Second-Quarter Results and Revised Fiscal 2017 Outlook 238
6.41 Oct 27, 2016: CRH Medical Announces Third Quarter 2016 Results 240
6.42 Oct 27, 2016: Thermo Fisher Scientific Reports Third Quarter 2016 Results 242
6.43 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016 243
6.44 Oct 26, 2016: Quidel Reports Third Quarter 2016 Financial Results 245
6.45 Oct 26, 2016: Allergan Announces Changes to Board Leadership 246
6.46 Oct 25, 2016: Bard Announces Third Quarter Results 247
6.47 Oct 25, 2016: Utah Medical Products Reports Financial Performance for Third Quarter 2016 247
6.48 Oct 24, 2016: McKesson Releases Fiscal 2016 Corporate Social Responsibility Report 251
6.49 Oct 24, 2016: Study links small RNA molecule to pregnancy complication 252
6.50 Oct 21, 2016: Viveve Files Patent Infringement Suit Against Thermi 253
6.51 Oct 20, 2016: Viveve Announces Regulatory Approval For Viveve System In Brazil 253
6.52 Oct 20, 2016: NanoVibronix Expands Senior Management Team and Board of Directors 253
6.53 Oct 19, 2016: Sonata Technology Platform Featured in Presentations at Upcoming Congress of the German Society of Obstetrics and Gynecology (DGGG) 254
6.54 Oct 18, 2016: Gynesonics Announces Early Completion of Enrollment in the SONATA FDA Clincial Trial for Incision Free Treatment of Symptomatic Uterine Fibroids 255
6.55 Oct 18, 2016: Contralateral prophylactic mastectomy is a popular treatment among breast cancer patients 255
6.56 Oct 17, 2016: Syneron Medical Strengthens Senior Management Team 256
6.57 Oct 17, 2016: Syneron Medical Announces Preliminary Third Quarter 2016 Revenue 257
6.58 Oct 14, 2016: Ovuline Raises USD10 Million in Venture Financing 257
6.59 Oct 13, 2016: Viveve Announces Regulatory Approval For Viveve System In U.A.E. And Lebanon 257
6.60 Oct 13, 2016: Merck Sets its Sights on 2018 and Outlines Future Strategic Roadmap 258
6.61 Oct 11, 2016: Fresenius Kabi Joins Chicago Health Innovation Incubator MATTER as Newest Strategic Partner 259
6.62 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer 259
6.63 Oct 06, 2016: Viveve Announces FDA 510(k) Clearance for the Viveve System in the U.S. 260
6.64 Oct 05, 2016: New Study Showcases Economic Impact of Allergan's Operations on New Jersey Economy 260
6.65 Oct 04, 2016: Bayer receives green light for new five-year contraceptive in the EU 262
6.66 Oct 04, 2016: Merck Launches Gavi oocyte protocol to Support Couples on Their Fertility Treatment Journey 262
6.67 Oct 04, 2016: Merck Launches Innovative Technology to Support Couples on Their Fertility Treatment Journey 263
6.68 Oct 03, 2016: Lawsuits Against Bayer Over Essure Birth Control Device Injuries To Be Coordinated Before A Single Judge Following Argument by Grant & Eisenhofer 264
6.69 Oct 03, 2016: LabCorp Acquires ClearPath Diagnostics from Shore Capital Partners 264
6.70 Oct 03, 2016: UE LifeSciences Raises USD1.2 Million in Venture Financing 265
7 Appendix 433
7.1 Methodology 433
7.2 About GlobalData 435
7.3 Contact Us 435
7.4 Disclaimer 436

1.1 List of Tables
Table 1: Women's Health - Pipeline Products by Stage of Development 28
Table 2: Women's Health - Pipeline Products by Territory 29
Table 3: Women's Health - Pipeline Products by Regulatory Path 30
Table 4: Women's Health - Pipeline Products by Estimated Approval Date 31
Table 5: Women's Health - Ongoing Clinical Trials 32
Table 6: Women's Health Companies - Pipeline Products by Stage of Development 33
Table 7: Women's Health - Pipeline Products by Stage of Development 37
Table 8: Accord Biomaterials, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
Table 9: Diagnostic Monitoring Tool - Preeclampsia - Product Status 41
Table 10: Diagnostic Monitoring Tool - Preeclampsia - Product Description 41
Table 11: Acelity L.P. Inc. Pipeline Products & Ongoing Clinical Trials Overview 42
Table 12: Strattice For Lumpectomy Reconstruction - Product Status 42
Table 13: Strattice For Lumpectomy Reconstruction - Product Description 42
Table 14: Advanced Prenatal Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
Table 15: Targeted Apheresis Cartridge For Preeclampsia - Product Status 43
Table 16: Targeted Apheresis Cartridge For Preeclampsia - Product Description 43
Table 17: AEGEA Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
Table 18: AEGEA Vapor System - Product Status 44
Table 19: AEGEA Vapor System - Product Description 44
Table 20: AEGEA Medical, Inc. - Ongoing Clinical Trials Overview 45
Table 21: AEGEA Vapor System - A Prospective, Multicenter, Clinical Trial to Evaluate the Safety and Effectiveness of the AEGEA Vapor System for the Treatment of Excessive Uterine Bleeding 46
Table 22: Aethlon Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 47
Table 23: HER2osome - Product Status 47
Table 24: HER2osome - Product Description 48
Table 25: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview 49
Table 26: Alyssa - Product Status 49
Table 27: Alyssa - Product Description 50
Table 28: Levosert - Contraception - Product Status 50
Table 29: Levosert - Contraception - Product Description 50
Table 30: Levosert - Heavy Bleeding - Product Status 51
Table 31: Levosert - Heavy Bleeding - Product Description 51
Table 32: LILETTA - 5 years - Product Status 51
Table 33: LILETTA - 5 years - Product Description 52
Table 34: Vaginal Ring Contraceptive - Product Status 52
Table 35: Vaginal Ring Contraceptive - Product Description 52
Table 36: AltaScience Limited Pipeline Products & Ongoing Clinical Trials Overview 53
Table 37: AltaSeal - Product Status 53
Table 38: AltaSeal - Product Description 53
Table 39: Amniotix Technologies Ltd Pipeline Products & Ongoing Clinical Trials Overview 54
Table 40: Amniotic Fluid Spectral Monitoring Device - Product Status 54
Table 41: Amniotic Fluid Spectral Monitoring Device - Product Description 54
Table 42: Aneeve Nanotechnologies LLC Pipeline Products & Ongoing Clinical Trials Overview 55
Table 43: Hormone Level Monitor - Product Status 55
Table 44: Hormone Level Monitor - Product Description 55
Table 45: Atossa Genetics Inc Pipeline Products & Ongoing Clinical Trials Overview 56
Table 46: FullCYTE Intraductal Microcatheter - Product Status 56
Table 47: FullCYTE Intraductal Microcatheter - Product Description 56
Table 48: Babyation LLC Pipeline Products & Ongoing Clinical Trials Overview 57
Table 49: Babyation Pump - Product Status 57
Table 50: Babyation Pump - Product Description 57
Table 51: Bayer AG Pipeline Products & Ongoing Clinical Trials Overview 58
Table 52: Kyleena - Product Status 58
Table 53: Kyleena - Product Description 59
Table 54: Next-Generation Essure Device - Product Status 59
Table 55: Next-Generation Essure Device - Product Description 60
Table 56: Bayer AG - Ongoing Clinical Trials Overview 60
Table 57: Next-Generation Essure Device - A Clinical Trial to Provide Immediate Contraception Using Next-Generation Essure 60
Table 58: Bayer HealthCare AG Pipeline Products & Ongoing Clinical Trials Overview 61
Table 59: LNG-IUS16 - Product Status 61
Table 60: LNG-IUS16 - Product Description 61
Table 61: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 62
Table 62: 3D Printed Pediatric Vaginal Stent - Product Status 62
Table 63: 3D Printed Pediatric Vaginal Stent - Product Description 62
Table 64: Baystate Medical Center Pipeline Products & Ongoing Clinical Trials Overview 63
Table 65: Expandable Pessaries - Product Status 63
Table 66: Expandable Pessaries - Product Description 63
Table 67: Becton Dickinson and Co Pipeline Products & Ongoing Clinical Trials Overview 64
Table 68: Odon Device - Product Status 64
Table 69: Odon Device - Product Description 65
Table 70: Bioceptive Inc Pipeline Products & Ongoing Clinical Trials Overview 66
Table 71: Intrauterine Device Inserter - Product Status 66
Table 72: Intrauterine Device Inserter - Product Description 66
Table 73: BioResonator Good Eye AB Pipeline Products & Ongoing Clinical Trials Overview 67
Table 74: Breast Checker - Product Status 67
Table 75: Breast Checker - Product Description 67
Table 76: Biorings LLC Pipeline Products & Ongoing Clinical Trials Overview 68
Table 77: Vaginal Ring - Product Status 68
Table 78: Vaginal Ring - Product Description 68
Table 79: Biostruxs LLC Pipeline Products & Ongoing Clinical Trials Overview 69
Table 80: BioBreast Scaffold - Product Status 69
Table 81: BioBreast Scaffold - Product Description 69
Table 82: Birmont Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 70
Table 83: Labor Progression Monitoring Device - Product Status 70
Table 84: Labor Progression Monitoring Device - Product Description 70
Table 85: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 71
Table 86: AUB Derivative Device - Product Status 71
Table 87: AUB Derivative Device - Product Description 72
Table 88: Obtryx System-Minimal Mesh Anterior-Apical Prolapse Repair - Product Status 72
Table 89: Obtryx System-Minimal Mesh Anterior-Apical Prolapse Repair - Product Description 72
Table 90: Cambridge Design Partner Ltd. Pipeline Products & Ongoing Clinical Trials Overview 73
Table 91: Uterine Balloon Tamponade - Product Status 73
Table 92: Uterine Balloon Tamponade - Product Description 73
Table 93: Cath Med Ltd. Pipeline Products & Ongoing Clinical Trials Overview 74
Table 94: Chorionic Villus Sampling Trans-Cervical Catheter - Product Status 74
Table 95: Chorionic Villus Sampling Trans-Cervical Catheter - Product Description 74
Table 96: Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 75
Table 97: CeraShield Intravaginal Silicone Ring - Product Status 75
Table 98: CeraShield Intravaginal Silicone Ring - Product Description 75
Table 99: CervoCheck, LLC Pipeline Products & Ongoing Clinical Trials Overview 76
Table 100: CervoCheck - Product Status 76
Table 101: CervoCheck - Product Description 76
Table 102: Conrad Pipeline Products & Ongoing Clinical Trials Overview 77
Table 103: Triple Protection Vaginal Ring - Product Status 77
Table 104: Triple Protection Vaginal Ring - Product Description 77
Table 105: Contramed LLC Pipeline Products & Ongoing Clinical Trials Overview 78
Table 106: LevoCept - Product Status 78
Table 107: LevoCept - Product Description 78
Table 108: VeraCept - Product Status 79
Table 109: VeraCept - Product Description 79
Table 110: Contramed LLC - Ongoing Clinical Trials Overview 79
Table 111: VeraCept - Study of the Veracept Intrauterine Device for Long Acting Reversible Contraception 80
Table 112: Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 81
Table 113: Magnetic Particle Heating System - Product Status 81
Table 114: Magnetic Particle Heating System - Product Description 81
Table 115: Discreet Secrete Solutions Pipeline Products & Ongoing Clinical Trials Overview 82
Table 116: Freedom Pump - Product Status 82
Table 117: Freedom Pump - Product Description 82
Table 118: Drexel University Pipeline Products & Ongoing Clinical Trials Overview 83
Table 119: Belly Band - Product Status 83
Table 120: Belly Band - Product Description 83
Table 121: DS Labs, Inc Pipeline Products & Ongoing Clinical Trials Overview 84
Table 122: Gala Pump - Product Status 84
Table 123: Gala Pump - Product Description 84
Table 124: Enox Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview 85
Table 125: Intra Vaginal Device - Product Status 85

1.2 List of Figures
Figure 1: Women's Health - Pipeline Products by Stage of Development 28
Figure 2: Women's Health - Pipeline Products by Territory 29
Figure 3: Women's Health - Pipeline Products by Regulatory Path 30
Figure 4: Women's Health - Pipeline Products by Estimated Approval Date 31
Figure 5: Women's Health - Ongoing Clinical Trials 32